Concurrent use of vinorelbine and gefitinib induces supra-additive effect in head and neck squamous cell carcinoma cell lines

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

Jay S. Cooper, Thomas F. Pajak, Arlene A. Forastiere et al. · New England Journal of Medicine · 2004 · 3.3K citations

Medicine, Oncology, Radiation Oncology +6

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

Masahiro Fukuoka, Seiji Yano, Giuseppe Giaccone et al. · Journal of Clinical Oncology · 2003 · 2.9K citations

Medicine, Oncology, Pharmacology +13

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer

Mark G. Kris, Ronald B. Natale, Roy S. Herbst et al. · JAMA · 2003 · 2.5K citations

Medicine, Oncology, Pharmacology +17

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

Jean Bourhis, C. Domenge, L. Designé · The Lancet · 2000 · 2.5K citations

Medicine, Oncology, Chemotherapy +8

Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer

David M. Brizel, MARY ALBERS, Samuel R. Fisher et al. · New England Journal of Medicine · 1998 · 1.1K citations

Medicine, Oncology, Radiation Oncology +9